Navigation Links
NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
Date:7/31/2008

table since inception. The resulting increase in leukemia/lymphoma cases received, which typically have 2-4 tests ordered for each requisition, led to an 8% increase in our overall average number of tests performed per requisition relative to Q1 08. Increases in this important metric lead to more operating leverage in our business, and we are hopeful that we can continue to increase it further in coming quarters."

Mr. Gasparini continued, "I am also pleased to report that despite our robust revenue growth, we were able to hold our SG&A expenses in check and finally begin to realize significant economies of scale on the investments in people and infrastructure we previously made. Indeed, SG&A expenses as a percentage of revenue decreased from approximately 88% in Q2 07 to approximately 52% in Q2 08. Furthermore, on a sequential basis, SG&A expenses increased by only $42,000 or 1.7% relative to Q1 08. All of these sequential increases were in our sales and marketing department where we continue to invest for growth, and the corporate general and administrative expenses were flat relative to the first quarter. Our strong revenue momentum coupled with our tight control of SG&A expenses enabled us to turn profitable for the second quarter. In fact, now that we have reached the inflection point in our business, we were able to turn 47% of the incremental $719,000 in revenue from Q1 08 into profits for the second quarter."

First Half Performance

For the first six months of 2008, revenue increased by 97% to $9.04 million from the comparable period in 2007. Requisitions increased by 72% and average revenue/requisition increased by 15%. Gross profit margin increased by approximately 110 basis points to 55.3% from 54.2% for the first six months of 2007. SG&A expenses increased by 45% to $5.07 million for the first six months of 2008. These increases in SG&A are primarily the result of adding sales and marketing and corporate personnel to continue to scale
'/>"/>

SOURCE NeoGenomics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. NeoGenomics Announces Results for the 3rd Quarter 2007
2. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
3. Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference
4. Lyriana Announces Antidepressants Now Linked to Declining Libido in Women
5. Hologic Announces Third Quarter Fiscal 2008 Operating Results
6. VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives
7. The Quantum Group Announces 2nd Statewide Contract
8. STERIS Corporation Announces Fiscal 2009 First Quarter Results
9. CutisPharma Announces Strategic Collaboration with Rite Aid Corporation
10. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
11. BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 2015 With more than 4,500 ... of osteoporosis, osteoarthritis and musculoskeletal diseases gathered here ... be the first time in the 17-year history ... the hot-button topic is an emerging non-pharmaceutical protocol ... scientific principles of Wolff’s law, osteogenic loading at ...
(Date:3/28/2015)... 2015 India Network visitor health ... available to all visitors who purchase the plan before ... are encouraged to purchase the insurance program as soon ... proper coverage for pre-existing medical conditions. Parents and grandparents ... medical conditions with serious consequences to their health. Many ...
(Date:3/28/2015)... One in three young athletes who ... today at the American Orthopaedic Society for Sports Medicine’s ... long term success of surgery for patients aged 18 ... from 242 patients who underwent ACL reconstruction between 1993 ... FRACS, from North Sydney Orthopaedic and Sports Medicine Centre. ...
(Date:3/28/2015)... Genomic medicine experts have sequenced the genomes ... first time, key information for understanding and treating this ... posted story on the Surviving Mesothelioma website. ... the British Columbia Cancer Agency, and PhenoPath lab in ... alterations and mutations that can lead to peritoneal ...
(Date:3/28/2015)... Healthpointe’s otolaryngologists, medical practitioners who attend ... disorders, are now offering a wide variety of treatments ... characterized by the presence of phantom sounds or ringing ... is a prevalent symptom that can arise due to ... tinnitus can impede a person’s quality of life. , ...
Breaking Medicine News(10 mins):Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2
... study finds , FRIDAY, Aug. 21 (HealthDay News) -- Imagine ... they take root in the brain. , That,s the promise ... -- assuming the findings can be applied to humans, that ... Rio Grande do Sul, Brazil, with colleagues at the University ...
... ... loss. , ... (PRWEB) August 22, 2009 -- Over 50 million American men suffer from hair loss. With ... and male pattern hair loss sufferer, Kevin Nalty (a.k.a. "Nalts") to raise awareness about hair ...
... , WINTER PARK, Fla., Aug. 17 ... Corporation clearance of its new MRidium 3860+ MRI Infusion System ... for Sedation, Critical Care, and Cardiac Patients to date has ... SpO2 being typically not designed to be integrated and functional ...
... , , SOLON, Ohio, Aug. ... U.S. marketplace, Nestle USA is pleased to announce that NESTLE TOLL ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090818/SF63053-a ) , (Photo: http://www.newscom.com/cgi-bin/prnh/20090818/SF63053-b ) ... retail partners and consumers to identify the new batch of cookie ...
... In the first in a series on evaluating eHealth ... Aziz Sheikh and Lorraine Catwell from The University of ... and discuss the importance of evaluating the widespread investments ... care. Funding: This work was supported by a ...
... over health care reform continues to unfold in town hall ... Harvard researchers has found that taxing job-based health benefits would ... regressivity of taxing employer-paid health insurance," appears in the August ... Medicine . It was written by Drs. David Himmelstein and ...
Cached Medicine News:Health News:Dopamine Lets Bad Experiences Linger 2Health News:Dopamine Lets Bad Experiences Linger 3Health News:Vlogging For Hair: YouTube Star 'Nalts' Promotes Hair Loss Awareness with Dr. Alan Bauman 2Health News:Vlogging For Hair: YouTube Star 'Nalts' Promotes Hair Loss Awareness with Dr. Alan Bauman 3Health News:Vlogging For Hair: YouTube Star 'Nalts' Promotes Hair Loss Awareness with Dr. Alan Bauman 4Health News:IRadimed Announces 510K Clearance of the New Non-Magnetic MRidium(TM) MRI IV Pump with Integrated Masimo SET(R) SpO2 Monitoring 2Health News:IRadimed Announces 510K Clearance of the New Non-Magnetic MRidium(TM) MRI IV Pump with Integrated Masimo SET(R) SpO2 Monitoring 3Health News:IRadimed Announces 510K Clearance of the New Non-Magnetic MRidium(TM) MRI IV Pump with Integrated Masimo SET(R) SpO2 Monitoring 4Health News:Updated With Photos: NESTLE(R) TOLL HOUSE(R) Re-launches With 'New Batch' Label 2Health News:eHealth interventions need to be continuously evaluated 2Health News:Harvard study reveals taxing job-based health benefits would hit working families hardest 2
(Date:3/27/2015)... 27, 2015 /CNW Telbec/ - Russell Williams , ... Companies (Rx&D), welcomes the 2015-2016 Quebec Budget, noting the ... on the biopharmaceutical industry. However, the association is concerned ... "We commend the government,s intent to strive for a ... to promote Quebec,s economic development ...
(Date:3/27/2015)... The Temple Health & Bioscience District (THBD) today announced it ... South First St. in the Temple Medical and Education District ... of Temple to receive funding for redevelopment. Located ... Health Care System, the new facility will enable THBD to ... life science companies. Temple ...
(Date:3/27/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is launching ... Available in both small (6mm) and large ... System from Zimmer is a modular system that offers surgeons ... XtraFix System allows surgeons to eliminate steps, as well ... in saved time, costs and overall team effort. ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3
... RDEA594 Data to Be Presented at the 2008 Annual European Congress of, Rheumatology ... Phase 1 Human Study of RDEA594 Planned in Second Half of ... ... Biosciences, Inc.,(Nasdaq: RDEA ) today announced the identification of its lead development,candidate ...
... filing anticipated in 1Q 2009 -, PRINCETON, ... ) has nominated PSI-7851 as a lead development ... (HCV). PSI-7851 is a proprietary,nucleotide analogue polymerase inhibitor ... Practice (GLP) animal toxicity studies required for,submission of ...
Cached Medicine Technology:Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C 2Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C 3
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This dissector offers dual-action jaws, which are long, tapered, and angled 30 to simplify even difficult laparoscopic dissection....
Medicine Products: